Qube Research & Technologies (QRT)
INFI

Qube Research & Technologies (QRT)’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-73,421
Closed -$87K – 3148
2022
Q3 		$87K Sell
73,421
-8,547
-10% -$9.22K ﹤0.01% 2011
2022
Q2 		$52K Buy
+81,968
New +$62.9K ﹤0.01% 2121
2021
Q3 		– Sell
-26,469
Closed -$79K – 2938
2021
Q2 		$79K Buy
+26,469
New +$83.7K ﹤0.01% 1976
2021
Q1 		– Sell
-29,087
Closed -$62K – 2539
2020
Q4 		$62K Sell
29,087
-91,781
-76% -$151K ﹤0.01% 1685
2020
Q3 		$141K Buy
120,868
+95,860
+383% +$98.5K ﹤0.01% 1454
2020
Q2 		$23K Buy
+25,008
New +$23.8K ﹤0.01% 1651

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Qube Research & Technologies (QRT)'s INFI Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2022, closing a stake of 73,421 shares — an estimated $87K sold.

Qube Research & Technologies (QRT) first reported a position in INFI in Q2 2020 and held it in 6 quarters. The position peaked at $141K in Q3 2020. 68 funds tracked by Wall St. Rank hold INFI as of Q4 2022.

  • Qube Research & Technologies (QRT) reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 73,421 Infinity Pharmaceuticals, Inc. shares in Q4 2022, an estimated $87K.
  • Qube Research & Technologies (QRT) first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2020 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Infinity Pharmaceuticals, Inc. position peaked at $141K in Q3 2020.
  • 68 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.